Vaccination against SARS-COV-2: one year after vaccination roll-out in Colombia
Vacunación contra SARS-COV-2: un año después de iniciada en Colombia
Show authors biography
Introduction: mass vaccination against COVID-19 begun in February 2021. As of February17 2022, 75’732.846 doses had been administered nationwide. Peak vaccination rates were achieved on August 6 2021 when 594.933 doses were administered. Objective: to show the SARS-COV-2 vaccination plan behavior in the period between February 17 2021 and February 17 2022. Methodology: a cross-sectional study was conducted. Data was obtained from the Ministry of Health and Social Protection website, based on the national COVID-19 vaccination plan reports. Results: the highest number of doses (10’117.202) was administered in November 2021, the highest number of second doses (3’469.508) was administered in June, the highest number of single doses (2’322.994), as well as the highest number of doses which completed primary vaccination courses (5’282.778) were applied in July, and the highest number of booster doses (2’390.185). was applied in January 2022. Conclusion: vaccination process follow-up, to understand vaccine effectiveness, likelihood of immune response decrease over time and possible adverse effects, is crucial. Tracking virus mutations detected in the country, affecting vaccine-induced immunity, is also essential.
Article visits 349 | PDF visits 179
Downloads
- Qin C, Zhou L, Hu Z, Zhang S, Yang S, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. doi: 10.1093/cid/ciaa248
- Yi Y, Lagniton PNP, Ye S, Li E, Xu RH. COVID-19: what has been learned and to be learned about the novel coronavirus disease. Int J Biol Sci 2020;16(10):1753–1766. doi: 10.7150/ijbs.45134
- Lurie N, Saville M, Hatchett R, Halton J. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med 2020;382(21):1969–1973. doi: 10.1056/NEJMp2005630
- Krammer F, Srivastava K, Alshammary H, Amoako AA, Awawda MH. Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine. N Engl J Med 2021;384(14):1372-1374.
- Baden LR, El Sahly HM, Essink B, Kotloff K, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med 2021;384(5):403–416. doi: 10.1056/NEJMoa2035389
- Radbruch A, Chang HD. A long-term perspective on immunity to COVID. Nature. 2021;595:359–360. https://doi.org/10.1038/d41586-021-01557-z
- Mahallawi W, Alzahrani M, and Alahmadey Z. Durability of the humoral immune response in recovered COVID-19 patients. Saudi J Biol Sci. 2021. doi: 10.1016/j.sjbs.2021.1002.1011
- Turner JS, Kim W, Kalaidina E, Goss CW, Rauseo AM, et al. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. 2021;595(7867):421–425. doi: 10.1038/s41586-021-03647-4
- Wang Z, Muecksch F, Schaefer-Babajew D, Finkin S, et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature 2021;595(7867):426–431. doi: 10.1038/s41586-021-03696-9
- Alsayb MA, Alsamiri ADD, Makhdoom HQ, et al. Prolonged humoral and cellular immunity in COVID-19-recovered patients. Saudi J Biol Sci 2021;28(7):4010–4015. doi: 10.1016/j.sjbs.2021.04.008
- Díaz Pinzón JE. Estimación de la prevalencia del COVID-19 en Colombia. Repert Med Cir. 2020;29(Núm. Supl. 1):99–102. https://doi.org/10.31260/RepertMedCir.01217372.1115
- Díaz Pinzón JE. Análisis de los resultados del contagio del COVID-19 respecto a su distribución geográfica en Colombia. Repert Med Cir. 2020;29(Núm. Supl. 1):60–64. https://doi.org/10.31260/RepertMedCir.01217372.1082
- Díaz Pinzón JE. Dinámica y relación del contagio del COVID-19 después de iniciado el plan de vacunación contra el SARS-COV-2 en Colombia. Repert Med Cir. 2021;30(Núm. Supl. 1): 41–45. https://doi.org/10.31260/RepertMedCir.01217372.1227
- Ministerio de Salud y Protección Social. Plan de vacunación nacional contra COVID-19 [Internet]. 2021 [Consultado 2021]. Disponible en: https://www.minsalud.gov.co/salud/publica/Vacunacion/Paginas/Vacunacion-covid-19.aspx13
- Díaz Pinzón JE. Cobertura de vacunación contra COVID-19 por esquema en Colombia. Repert Med Cir. 2021;30(Núm. Supl. 1):114-117. https://doi.org/10.31260/RepertMedCir.01217372.1280
- Mahallawi WH, Fakher MH, Alsarani MA, Aljohani RH, AL-Mutabgani SA, Ibrahim NA. A Single Dose of SARS-CoV-2 Vaccine Primes a Strong Humoral Immune Response in COVID-19-Recovered Patients. Viral Immunol. 2022;35(2):122-128. https://doi.org/10.1089/vim.2021.0108
Information
Keywords
